July 19, 2019
Acerus Pharmaceuticals (TSX:ASP, OTCQB:ASPCF) has announced it has entered into a US$5 million subordinated secured term loan facility with First...
June 6, 2019
INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019
BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 10, 2019
In this BBHIC interview, Acerus Pharmaceuticals CEO Ed Gudaitis explains why the company isn't directly pursuing the cannabis market.
May 1, 2019
The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
March 5, 2019
Shares of Acerus Pharmaceuticals dipped 7.14 percent on Tuesday following the release of its Q4 and fiscal 2018 financial results.
January 25, 2019
Acerus Pharmaceuticals (TSX:ASP) is today advising that it has received a Notice of Deficiency-Withdrawal Letter for its Gynoflor New Drug Submission....